In epithelial ovarian cancer (EOC), tumor-associated macrophages promote angiogenesis via IGF-I secretion in response to angiopoietin-2 (Ang2), highlighting IGF1 as a potential therapeutic target [67]. This evidence concerns the gene IGF1 and neoplasm.